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have demonstrated that blood lymphocyte CYP1A1 could be used a 
biomarker to predict lung cancer.
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Background: Occupational exposure to asbestos is associated with the 
development of asbestosis, malignant mesothelioma, and lung cancer. 
Research related to the mechanisms by which asbestos ﬁbers cause 
damage in the cells and which are the mediator genes is important as 
exact mechanisms underlying asbestos-associated carcinogenesis are 
not known. Knowledge about the genome-wide alterations involved in 
asbestos-associated carcinogenesis can be obtained by characterizing 
changes in gene expression after exposure to the carcinogen or between 
asbestos-exposed and non-exposed patients using microarrays. 
Methods: We have previously analyzed the DNA copy number and 
gene expression proﬁles of 14 lung tumors from highly asbestos-ex-
posed and 14 non-exposed patients using microarrays and revealed 
that a speciﬁc aberration proﬁle could be characteristic of lung tumors 
associated with asbestos-exposure. Furthermore, by exposing human 
epithelial and metsothelial cells to crocidolite asbestos and performing 
time-series microarray experiments, we have recently reported asbes-
tos-exposure related temporal changes in gene expression proﬁles. In 
this study, the gene expression microarray data from these experiments 
were combined. Promoter sequence analysis was ﬁrst applied to clus-
ters of co-expressed genes detected from the cell line data to identify 
genes that are likely co-regulated by the same mechanisms. Thereafter, 
common changes between the cell line and patient data were revealed.
Results: 15 transcription factors were identiﬁed to be under-represent-
ed in the promoter regions of genes with similar temporal expression 
proﬁles in comparison to the remaining genes on the array (p<0.00001). 
Among the under-represented transcription factors were those that have 
been previously associated with regulation of mitochondria, oxidative 
stress, and carcinogenesis but not with exposure to asbestos.
Conclusions: The study provides new information about putative 
transcription factors and mediator genes involved in asbestos-associ-
ated carcinogenesis. We show that the integration of gene expression 
data from cell line and human studies gives insight of the mechanisms 
underlying asbestos-related carcinogenesis.
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Background: Globally, lung cancer is the most frequent cancer today 
and is expected to have a major impact on human health throughout the 
next decades. The role of tobacco smoking as a major etiologic factor 
of this malignancy is well established. The gene- environment interac-
tion for cancer development is largely attributed to the action of xeno-
biotic metabolizing enzymes (XME). Genetic polymorphism is known 
for the xenobiotic metabolizing cytochrome P450 (CYPs), the phase I 
enzymes and glutathione-S- transferases (GST), the phase II enzymes, 
involved in the process of carcinogenesis. As not much information is 
available on the polymorphism of CYP and GST isoenzymes in Indian 
population, the present case-control study attempted to investigate the 
association of polymorphism in CYP1A1, 1B1 and GSTM1 and the 
combination of these important polymorphisms with squamous cell 
carcinoma of lung malignancy. 
Methods: Patients suffering from squamous cell carcinoma of lung 
(n=140) and visiting OPD facility of Department of Radiotherapy, 
King George’s Medical University, Lucknow, India were included in 
the study. Equal number of age- and sex matched healthy individuals 
were also enrolled in the study. After obtaining detailed information 
from each individual, 1.0 ml blood was drawn from them which were 
processed for isolation of DNA. PCR ampliﬁcation were carried for 
studying the polymorphisms in CYP1A1, CYP1B1 and GSTM1 using 
the standardized protocols. 
Results: Our data revealed that the variant alleles of CYP1A1 (both, 
Msp1, Ile/ Val and BSaI) were found to be signiﬁcantly overrepre-
sented in the lung cancer patients when compared with the controls. 
Haplotype analysis revealed that haplotype, C-A-C and A-A-T were 
associated with signiﬁcant increase in the lung cancer risk. As observed 
with CYP1A1, the frequency of the variant genotype of CYP1B1 
(Arg48Gly/ Ala119Ser and Leu/432Val) were signiﬁcantly increased 
in the patients resulting in signiﬁcant increase in the lung cancer risk. 
Haplotypes having 48arginine, 119alanine, 432leucine and 453serine 
or 48glycine, 119serine, 432valine and 453aspargine were found to be 
more prevalent in the cases and were associated with signiﬁcant in-
crease in the lung cancer risk. Cigarette smoking and tobacco chewing 
was further found to increase the risk in the cases. The genotype com-
binations of CYP1A1 and CYP1B1 increased several folds (6-8 folds) 
the risk associated with lung cancer. Likewise, combination of variant 
genotypes of CYP1A1 with null genotype of GSTM1 also increased 
the risk in the cases. 
Conclusion: Our case-control study have shown that polymorphism 
in CYP1A1 and CYP1B1 may modify the risk to lung cancer. Hap-
lotype approach revealed an stronger association of CYP1A1 or 1B1 
haplotypes with risk to lung cancer. The increase in risk in cases was 
further found to be increased in cases carrying combination of variant 
genotypes of CYP1A1 and 1B1 and GSTM1. Furthermore several fold 
increase in the risk in smokers and tobacco chewers have demonstrated 
the importance of gene-environment interactions in the pathogenesis of 
lung cancer.
